The CJC-1295 + Ipamorelin combination unites two distinct peptide classes: a GHRH analogue (CJC-1295 without DAC) and a selective GH secretagogue (Ipamorelin). Together, they are studied for their ability to stimulate growth hormone release through complementary pathways — promoting both amplitude and frequency of GH pulses.
This pairing has gained attention in research focused on physical recovery, body composition, sleep quality, and age-associated reductions in endogenous hormone output, with minimal impact on cortisol or prolactin levels.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
